American Gene Technologies International Stock
American Gene Technologies develops bio-safe lentivirus therapies to treat cancer, HIV/AIDS, and other chronic human disorders.
Sign up today and learn more about American Gene Technologies International Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About American Gene Technologies International Stock
American Gene Technologies is a gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications. It develops bio-safe lentivirus therapies to treat cancer, HIV/AIDS, and other chronic human disorders. The company's mission is to leverage the power of gene and cell therapy to reduce human suffering from serious human diseases. American Gene Technologies was established in 2007 and is headquartered in Rockville, Maryland.
Funding History
| September 2013 | $1.3M |
|---|---|
| October 2014 | $340K |
Management
CEO & Founder
Jeffrey A. Galvin
Press
lifescivoice - May, 25 2022
Why Focus on Treating Diseases Instead of Curing Them?americangene - May, 25 2022
American Gene Technologies Attracts Investment from Ride Wave Venturesamericangene - May, 25 2022
American Gene Technologies Advances Closer to Demonstrating a Potential Cure for HIVwjla - May, 25 2022
American Gene Technologies says clinical trial shows increases in immunity against HIVamericangene - May, 25 2022
American Gene Technologies’ HIV Clinical Trial Shows Blood Markers of Efficacy in Two More Patientsamericangene - May, 25 2022
American Gene Technologies’ HIV Clinical Trial Demonstrates Blood Markers of Efficacyamericangene - May, 25 2022
American Gene Technologies Appoints Dr. Marcus A. Conant as Special Advisor to the CEOamericangene - May, 25 2022
American Gene Technologies Appoints Dr. Robert R. Redfield as Special Advisor to the CEOamericangene - May, 25 2022
HIV Cure Program Releases Initial Clinical Trial Dataamericangene - May, 25 2022
LGBT+ Investment Firm Gaingels Joins American Gene Technologies’ Mission to Cure HIV, and Other Serious Human Diseaseswashingtonblade - May, 25 2022
NIH launches $100 million effort to cure HIV, sickle cellnews-medical - Mar, 21 2018
American Gene Technologies receives second immuno-oncology patentmarketwired - Apr, 17 2017
American Gene Technologies Announces C. Neil Lyons as Chief Financial Officerprweb - Mar, 20 2017
American Gene Technologies Announces Collaboration with GeoVax for HIV Functional Curemarketwired - Mar, 14 2017
GeoVax Announces Collaboration with American Gene Technologies for HIV Functional CureEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
